The Perioperative Pivot: Navigating the new frontier for immunotherapy in early-stage cancers

From this point of view, life-science teams will learn how to:

  • Align on a consistent definition of "high‑risk" patients across the multidisciplinary care team.
  • Translate event‑free and disease‑free survival into clear value stories for stakeholders beyond medical oncology.
  • Close handoff gaps between diagnosis, surgery, and systemic treatment to ensure eligible patients remain on the treatment pathway.

Authors:

Joel Sandler, PhD, Associate Partner, Healthcare (US)
Eric Blouin, BHSc, Senior Vice President Oncology, Healthcare (US)


Connect with our team of oncology experts at: [email protected]







John Doe
Position
Jane Doe
Position
Joe Doe
Position
John Doe
Position
Jane Doe
Position
Joe Doe
Position
John Doe
Position
Jane Doe
Position
Joe Doe
Position